We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2026 GOLD report newly highlights disease activity ...

It’s a simple question that physicians usually do not ask their patients: “When was your last drink?” “If the patient says yesterday, you know the patient isn’t a casual drinker,” said Joe G. Zein, MD ...

Chronic obstructive pulmonary disease and cardiovascular diseases are among the leading chronic health burdens worldwide. They share key modifiable risk factors as well as overlapping ...

Building the ER on a 24,000 square foot space, Ruscio always wanted to stay as accurate as possible so the audience would stay immersed in the story. By Beatrice Verhoeven Awards Editor Nina Ruscio, ...

Mepolizumab targets IL-5, addressing eosinophilic inflammation in 20%-40% of COPD patients, marking its fifth US indication. The phase 3 MATINEE trial showed a 21% reduction in annualized moderate or ...

Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...

An ER reunion took place this week on the Great White Way, and nobody was hospitalized! As George Clooney made his Broadway debut Thursday in the stage adaptation of his 2005 Oscar-nominated film Good ...

Arezou is a writer for Collider. She has a wide-ranging knowledge of movies and TV, which means she almost certainly will start quoting something mid-conversation. While she has always wanted to work ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially ...

A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options. We live longer and longer, and as we age ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...